Exercise and GLP-1 to improve insulin and muscle blood flow
Treatments studied
Part of Hormones & metabolism clinical trials.
This study looks at whether doing exercise and a GLP-1 medicine (liraglutide or similar) can improve how your body uses insulin and how blood flows to your muscles. It is aimed at adults with metabolic syndrome who do not already have diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 21 and 60 years old
- Have a BMI over 25 but not above 35, and your weight must be stable recently
- Meet at least 3 out of 5 metabolic syndrome signs (waist size, triglycerides, HDL, blood pressure, or fasting glucose)
- Have no history of diabetes and have never used diabetes medicines
- Be able to safely do an exercise program and not have done regular moderate/high exercise recently
- Not be pregnant or breastfeeding, and not be allergic to perflutren
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if empagliflozin, a medication typically used for diabetes, can help people with metabolic syndrome (a cluster of conditions like large waist size, high blood sugar, and high blood pressure). It may improve health and reduce the risk of heart disease.
This trial tests a lifestyle program combined with two medications (semaglutide and dapagliflozin) to help people with metabolic syndrome lose weight and improve their health. It may be an option if you are an adult with a BMI of 27 to 45 and have metabolic syndrome.
This study tests if combining exercise with a drug called liraglutide improves blood vessel health and insulin sensitivity in people with type 2 diabetes. It looks at whether these treatments work better together or alone.
This trial tests whether combining a GLP-1 medication (a type of diabetes drug that also helps with weight loss) with an exercise program can improve physical function in people with obesity. If you are obese and have trouble with daily activities, this study may help you become more mobile and healthier.
This study tests whether a 12-week program of exercise and personalized nutrition counseling can help obese adults maintain muscle and bone while taking GLP-1 medications (drugs that help with weight loss). GLP-1 drugs can sometimes cause muscle loss, so this trial explores whether targeted exercise and nutrition can prevent that.
This study tests if a weekly injection (semaglutide) combined with an exercise program can help reduce fat stored in the heart and muscles in people with type 2 diabetes. It may improve how well your body handles sugar and lowers your risk for heart problems.
Hear when a new Metabolic Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.